Clinical Trial Update: Study of GBT021601 in Participants With Renal Impairment [Phase 1]

View source ↗

Summary

Pfizer's Phase 1 study of GBT021601 in participants with renal impairment has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• GBT021601

Snippet

Sponsor: Pfizer | Conditions: Renal Impairment | Phase 1 | Status: TERMINATED